Aerosolised medicines may reduce the high risk of coronavirus infection

pre-exposure COVID treatment

Rapid development of vaccines and other preventative measures has been vital in the response to the COVID-19 pandemic. Dr Michael Dubina, full member of the Russian Academy of Sciences, explores a novel method to reduce coronavirus infection risk. His pilot study explored the effects of an aerosolised combination medication in healthcare workers who had not previously been infected with the […]

Read More…

Laboratory lungs: The implications of lung organoids for health and disease

Dr Leibel has developed stem cell-derived lung organoids to learn more about lung development.

Lung disease is a major public health concern. However, research is hindered by the challenges of developing translatable human lung systems in a laboratory setting. Dr Sandra Leibel, neonatologist and Physician Scientist at UCSD and Rady Children’s Hospital in San Diego, USA, is studying lung development and disease mechanisms. In order to do this, she has developed stem cell-derived lung […]

Read More…

Understanding the impact of Mycoplasma ovipneumoniae in domestic sheep

Biology Understanding the impact of Mycoplasma ovipneumoniae in domestic sheep

Mycoplasma ovipneumoniae is frequently present in domestic sheep operations and is associated with negative effects on productivity and profitability. Infection of a flock with this pathogen may increase frequency of pneumonia, reduce lambing rates, and impair feed efficiency, resulting in significant financial costs. In addition, presence of this pathogen is associated with increased risk for nearby wild bighorn sheep, which […]

Read More…

Thank you for expressing interest in joining our mailing list and community. Below you can select how you’d like us to interact with you and we’ll keep you updated with our latest content.

You can change your preferences or unsubscribe by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at at any time and if you have any questions about how we handle your data, please review our privacy agreement.

Would you like to learn more about our services?

We use MailChimp as our marketing automation platform. By clicking below to submit this form, you acknowledge that the information you provide will be transferred to MailChimp for processing in accordance with their Privacy Policy and Terms.

Subscribe to our FREE PUBLICATION